13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q1 2025 · Filed April 11, 2025 · Accession 0000950123-25-003449
Total Value
$437.7M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $287.1M | 65.59% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $58.7M | 13.42% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $46.8M | 10.69% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 22,352,000 | $27.3M | 6.23% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $17.8M | 4.07% |